Abstract:Many viruses can cause infections in mink, including canine distemper virus, mink enteritis virus, and Aleutian disease virus. Current treatments are ineffective, and these infections are often fatal, causing severe economic losses. As antiviral drugs may effectively prevent and control these infections, recent research has increasingly focused on antiviral interferons. Herein, the gene encoding a mature mink interferon alpha (MilFN-alpha) was synthesized according to the P pastoris preference of codon usage and a recombinant plasmid, pPICZ alpha A-MilFN-alpha, was constructed. pPICZ alpha A-MilFN-alpha was linearized and transformed into the P. pastoris X33 strain, and zeocin-resistant transformants were selected. Protein expression was induced by methanol. SDS-PAGE and western blot analyses showed that a 25-kDa fusion protein was expressed in the culture supernatant. Antiviral activity of the expressed protein was determined using cytopathic effect inhibition (CPEI). The purified MilFN-alpha significantly inhibited the cytopathic effect of vesicular stomatitis virus with a green fluorescent protein (VSV-GFP) in F81 feline kidney cells, with an antiviral activity of 6.4 x 10(7) IU/mL; it also significantly inhibited MEV replication in F81 cells. MilFN-alpha antiviral activity against VSV-GFP was significantly reduced on treatment with pH 4 and pH 10 conditions for 24 h (p < 0.01). Serum MiIFN-alpha concentrations in rat were measured using enzyme-linked immune-sorbent assay; MilFN-alpha concentrations in rat serum peaked at similar to 36h after injection. A high dose of MilFN-alpha was safe for use. There were no significant differences in body temperature, tissue changes, and lymphocyte, total white blood cell, and central granulocyte counts between the injected and control groups (p > 0.05). These findings lay a foundation for the large-scale production of recombinant MilFNs.

Yak Interferon-Alpha Loaded Solid Lipid Nanoparticles for Controlled Release

Hydrophilic Biodegradable Microspheres of Interferon-Alpha and Its Pharmacokinetics in Mice.

Multivesicular Liposome Formulations For The Sustained Delivery Of Interferon Alpha-2b

Multivesicular liposome formulations for the sustained delivery of interferon α-2b

The Preparation and Research of Vitro-release of Interferon-loaded Microspheres

Enhancing the antivirus activity of chimeric canine interferon with ricin subunit B by using nanoparticle formulations.

Preparation and evaluation of microencapsulated delivery system of recombinant interferon alpha protein from rainbow trout

Preparation of Bioactive Interferon Alpha-Loaded Polysaccharide Nanoparticles Using a New Approach of Temperature-Induced Water Phase/water-Phase Emulsion.

Oral Administration of Inflammatory Microenvironment-Responsive Carrier-Free Infliximab Nanocomplex for the Targeted Treatment of Inflammatory Bowel Disease

Expression of porcine interferon-α and its bioactivity analysis in vitro and in vivo

Construction and characterization of a potent, long-lasting recombinant human serum albumin-interferon α1 fusion protein expressed in Pichia pastoris

Modeling the Interaction of Interferon Α-1B to Bovine Serum Albumin As a Drug Delivery System.

Retracted: Preparation of Bioactive Interferon Alpha-Loaded Polysaccharide Nanoparticles Using A New Approach of Temperature-Induced Water Phase/Water-Phase Emulsion (retracted Article. See Vol. 13, Pg. 2277, 2018)

Adjuvant effect enhancement of porcine interleukin-2 packaged into solid lipid nanoparticles

Antiviral activity of mink interferon alpha expressed in the yeast <i>Pichia pastoris</i>

Preparation and characterization of a potent, long-lasting recombinant human serum albumin-interferon-α2b fusion protein expressed in Pichia pastoris

Development and in Vitro Release of Isoniazid and Rifampicin-Loaded Bovine Serum Albumin Nanoparticles

Preparation of recombinant canine interferon α and a comparative study of its biological activity

[Expression, Purification of Recombinant Luxi Yellow Cattle IFN-alpha Fusion Protein and Its Antiviral Activities].

Expression and purification of chicken beta interferon and its antivirus immunological activity.

Expression and Purification of Canis Interferon Α in Escherichia Coli Using Different Tags